Health Care & Life Sciences » Pharmaceuticals | Brooks Laboratories Ltd.

Brooks Laboratories Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
300
229
22
18
20
Total Accounts Receivable
185
242
234
138
102
Inventories
66
76
68
83
114
Other Current Assets
-
146
1
1
61
Total Current Assets
697
548
325
240
296
Net Property, Plant & Equipment
597
692
1,034
1,198
1,245
Total Investments and Advances
-
-
10
9
21
Long-Term Note Receivable
57
65
-
-
-
Other Assets
43
38
166
193
57
Total Assets
1,404
1,354
1,528
1,657
1,727
ST Debt & Current Portion LT Debt
1
5
54
30
85
Accounts Payable
123
191
159
184
265
Income Tax Payable
80
7
12
10
-
Other Current Liabilities
55
15
54
25
48
Total Current Liabilities
259
217
279
248
398
Long-Term Debt
-
-
3
108
173
Provision for Risks & Charges
6
7
8
10
11
Deferred Taxes
16
13
15
25
107
Total Liabilities
281
240
308
417
582
Common Equity (Total)
1,123
1,114
1,220
1,240
1,145
Total Shareholders' Equity
1,123
1,114
1,220
1,240
1,145
Total Equity
1,123
1,114
1,220
1,240
1,145
Liabilities & Shareholders' Equity
1,404
1,354
1,528
1,657
1,727

About Brooks Laboratories

View Profile
Address
502, Kanakia Atrium-2
Mumbai Maharashtra 400093
India
Employees -
Website http://www.brookslabs.net
Updated 09/14/2018
Brooks Laboratories Ltd. is a research and development driven pharmaceutical manufacturing company. It offers a range of pharmaceutical and medical drugs products such as liquid injection, dry powder injection, carbapenem dry powder injectables, tablets, and oral suspension. The company was founded by Atul Ranchal and Rajesh Mahajan on January 23, 2002 and is headquartered in Mumbai, India.